Private Equity

Updated:

Eastern Link Capital

Eastern Link Capital is a China-focused investment firm that invests in late stage and middle market companies in consumer spending and information technology...

Eastern Link Capital logo

Eastern Link Capital

Eastern Link Capital is a China-focused investment firm that invests in late stage and middle market companies in consumer spending and information technology sectors. The firm has made 15 investments, including a 2019 investment in Sinopharm Animal Health. Eastern Link Capital has one portfolio exit, IdentityMind Global, which was exited in March 2020.

General information

Firm type

Private Equity

Year founded

AUM

Undisclosed

Location

Region

Asia

Country

China

City

Beijing

Corporate office

Beijing, China

Sector focus

Private EquityVenture Capital

Frequently asked questions

What stages does Eastern Link Capital target?

Records list buyout, seed, start-up, expansion, growth, and general venture stages.

Where is Eastern Link Capital headquartered?

The firm is based in Beijing, China.

Does Eastern Link Capital publish AUM figures?

No AUM number is disclosed in available sources.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Beijing Private Equity profiles